Report

Paul Weiss, Goodwin Steer Lilly's $1.5B Calytrix Bio Buy

Report from the legal press

Headline as published by Law360 Life Sciences on Nov 16, 2026; collected by the wire Nov 16, 2026, 7:31 PM ET.

Read at Law360 Life Sciences

Coverage

  1. Law360 Life Sciences Legal press

    Paul Weiss, Goodwin Steer Lilly's $1.5B Calytrix Bio Buy

Named in this story

  • FirmLaw360Linked on a hard id: the report is published on the firm’s own domain (law360.com).

Topics

  • Drugs and medical devicesFrom the publisher’s section: no phrase in the text matched, so the tag comes from where Law360 Life Sciences filed it.

Explore the named firms, organizations and MDL dockets above. Sources and method